Arab Israeli Conflict
Middle East News
Hi Tech News
Researchers at the Faculties of Biology and Computer Science at the Technion-Israel Institute of Technology in Haifa have engineered a new drug that combines several different strains of antibiotics.
"There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB," WHO director-general Dr. Tedros Ghebreyesus said.
Antibiotic resistance can affect anyone, of any age, in any country.
Please insert a valid email address